Table 4.

Pathway enrichment analysis of red gene module for drug treatment in NPCs.

Source	Term	Q value
CORUM	AML1-HIPK2-p300 complex	0.017
CORUM	EGR-EP300 complex	0.023
CORUM	DNA polymerase alpha-primase complex	0.042
CORUM	TNF-alpha/NF-kappa B signaling complex 9	0.043
GO:BP	cell morphogenesis	9.93E−09
GO:BP	neuron development	4.57E−07
GO:BP	neuron projection development	7.92E−07
GO:BP	cell morphogenesis involved in differentiation	2.46E−06
GO:BP	neuron differentiation	3.78E−06
GO:BP	anatomical structure morphogenesis	5.15E−06
GO:BP	generation of neurons	5.51E−06
GO:BP	neurogenesis	7.43E−06
GO:BP	cell projection morphogenesis	4.04E−05
GO:BP	cellular component morphogenesis	5.32E−05
GO:BP	cell part morphogenesis	8.74E−05
GO:BP	plasma membrane bounded cell projection morphogenesis	1.07E-04
GO:BP	nervous system development	1.19E-04
GO:BP	neuron projection morphogenesis	1.78E-04
GO:BP	cell morphogenesis involved in neuron differentiation	3.17E-04
GO:BP	plasma membrane bounded cell projection organization	3.18E-04
GO:BP	cell projection organization	4.36E-04
GO:BP	morphogenesis of an epithelium	8.95E-04
GO:BP	regulation of cell projection organization	0.001
GO:BP	tissue morphogenesis	0.001
GO:BP	regulation of plasma membrane bounded cell projection organization	0.002
GO:BP	regulation of neuron projection development	0.004
GO:BP	axon development	0.004
GO:BP	cell development	0.0067
GO:BP	system development	0.006
GO:BP	positive regulation of cell projection organization	0.023
GO:BP	axonogenesis	0.027
GO:BP	regulation of anatomical structure morphogenesis	0.033
GO:BP	developmental growth	0.040
MIRNA	hsa-miR-218-5p	0.002
REAC	Nervous system development	0.013
REAC	Axon guidance	0.033
REAC	Attenuation phase	0.049
WP	Pathways Affected in Adenoid Cystic Carcinoma	2.59E-04
WP	Mesodermal Commitment Pathway	0.028